SEL-10 Activators encompass a diverse array of chemical compounds that indirectly augment the ubiquitin ligase activity of SEL-10 through various cellular signaling pathways and molecular mechanisms. Forskolin, by raising intracellular cAMP levels, could indirectly enhance SEL-10 activity through PKA-dependent phosphorylation mechanisms, potentiallyincreasing its affinity for target proteins involved in cell cycle regulation and Wnt signaling. This heightened activity is essential for the fidelity of protein ubiquitination and subsequent degradation processes that SEL-10 is known to govern. Similarly, MG132 and Epoxomicin serve as proteasome inhibitors, leading to an accumulation of ubiquitinated proteins within the cell. This build-up may indirectly necessitate an increase in SEL-10's ubiquitin ligase activity as the cell strives to maintain protein homeostasis. The inhibition of GSK-3 by LiCl, BIO, Indirubin-3'-monoxime, and SB216763 results in the stabilization of β-catenin, a substrate of SEL-10, which may in turn enhance the ubiquitin ligase's targeting of β-catenin for degradation, thereby restoring cellular equilibrium.
In addition to these, Roscovitine and PD0332991 act as cyclin-dependent kinase (CDK) inhibitors disrupting cell cycle progression, which could indirectly necessitate a higher functional output from SEL-10 as it targets cell cycle-related proteins for ubiquitination and degradation. Bortezomib, by impeding the proteasomal breakdown pathway, could similarly invoke a compensatory response, enhancing the ubiquitin ligase activity of SEL-10. The role of SEL-10 is further emphasized in the presence of S-Trityl-L-cysteine, which inhibits mitotic kinesin Eg5, leading to cell cycle arrest and potentially a greater reliance on SEL-10 for the degradation of regulatory proteins. Lastly, Trichostatin A, by altering gene expression through histone deacetylation inhibition, could create a broader spectrum of proteins requiring ubiquitination, indirectly enhancing the role of SEL-10 in maintaining protein quality control. These chemical activators, through their targeted influence on various molecular pathways and cellular processes, collectively contribute to the upregulation of SEL-10's ubiquitin ligase activity without directly modifying its expression or invoking its intrinsic activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can activate PKA. PKA can phosphorylate SEL-10, which may enhance its role in the ubiquitination and degradation of target proteins. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins. This can indirectly increase the functional demand on SEL-10's activity in the ubiquitin-proteasome pathway. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Epoxomicin is a selective proteasome inhibitor. By preventing the degradation of ubiquitinated proteins, it could indirectly enhance the activity of SEL-10 as the cell attempts to compensate for proteasome inhibition. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
BIO is a GSK-3 inhibitor, which may lead to increased levels of β-catenin. SEL-10, which targets β-catenin for proteasomal degradation, could be indirectly activated to restore cellular homeostasis. | ||||||
Indirubin-3′-monoxime | 160807-49-8 | sc-202660 sc-202660A sc-202660B | 1 mg 5 mg 50 mg | $77.00 $315.00 $658.00 | 1 | |
This compound is a GSK-3 inhibitor, potentially causing an increase in β-catenin levels, thereby possibly enhancing the activity of SEL-10 in targeting β-catenin for ubiquitination and degradation. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
SB216763 is another GSK-3 inhibitor that may indirectly enhance the activity of SEL-10 through increased levels of β-catenin, which SEL-10 may target for degradation. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Roscovitine is a CDK inhibitor which could disrupt the cell cycle and increase the need for SEL-10's regulatory role in ubiquitination of cyclin-dependent kinase inhibitors. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, a proteasome inhibitor, may increase the demand on SEL-10's ubiquitin ligase activity as the cell attempts to regulate protein levels through ubiquitination. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $31.00 $65.00 | 6 | |
A selective inhibitor of mitotic kinesin Eg5 which can lead to cell cycle arrest at the mitotic phase, potentially requiring enhanced activity of SEL-10 in the degradation of regulatory proteins. | ||||||